Kao Corp. Stock
€17.52
Your prediction
Kao Corp. Stock
Pros and Cons of Kao Corp. in the next few years
Pros
Cons
Performance of Kao Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Kao Corp. | 1.620% | -1.119% | -49.884% | -55.396% | -49.708% | -48.552% | -67.284% |
| Unicharm Corp. | -0.960% | -3.774% | 0.990% | - | 4.938% | - | - |
| Pola Orbis Holdings Inc. | 1.450% | -2.128% | 3.759% | -5.479% | -0.719% | -45.238% | -67.757% |
| Kose Corp | 1.390% | -1.342% | 10.526% | -9.816% | 5.000% | -65.207% | -78.382% |
News
Claude responded: Alignment Healthcare's CEO Sold Shares — But the Real Risk Is Policy, Not InsidersAlignment Healthcare's CEO Sold Shares — But the Real Risk Is Policy, Not Insiders
On May 11, 2026, John E. Kao, Chief Executive Officer of Alignment Healthcare (NASDAQ:ALHC), reported the indirect sale of 298,000 shares of common stock for a total transaction value of
Alignment Healthcare Backs Q2 Outlook as Stable Costs, New Markets Lift Margin Hopes
Alignment Healthcare (NASDAQ:ALHC) executives said the company remains confident in its second-quarter outlook, citing stable medical cost
Alignment Healthcare CEO Sells $2.1 Million in Shares. Here's What Investors Should Know
John E. Kao, Chief Executive Officer of Alignment Healthcare (NASDAQ:ALHC), reported the indirect sale of 118,000 shares for a transaction value of about $2.06 million, according to a SEC Form 4


